SCHEMBL10295575

SCHEMBL10295575

COP(=O)(O)OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@@H]1O

nearest known ligand 0.53

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
▸ FBP1 P09467 1/20 0.53
▸ AMDHD2 Q9Y303 1/20 0.49
▸ P2RY14 Q15391 6/20 0.46
▸ P2RY2 P41231 3/20 0.44
▸ P2RY4 P51582 2/20 0.44
▸ IGF2R P11717 4/20 0.42
▸ MACROD2 A1Z1Q3 1/20 0.41
▸ SIRT6 Q8N6T7 1/20 0.41
▸ MACROD1 Q9BQ69 1/20 0.41
▸ TRPM2 O94759 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14258149 0.85 FBP1 (0.50) FBP1AMDHD2P2RY14P2RY2P2RY4
SCHEMBL14258148 0.85 FBP1 (0.50) FBP1AMDHD2P2RY14P2RY2P2RY4
SCHEMBL5059685 0.83 FBP1 (0.58) FBP1AMDHD2P2RY14P2RY2P2RY4
SCHEMBL19760432 0.83 FBP1 (0.53) FBP1AMDHD2P2RY14P2RY2P2RY4
SCHEMBL5063577 0.83 FBP1 (0.58) FBP1AMDHD2P2RY14P2RY2P2RY4
SCHEMBL13828785 0.83 FBP1 (0.56) FBP1AMDHD2P2RY14P2RY2P2RY4
SCHEMBL10295498 0.83 FBP1 (0.56) FBP1AMDHD2P2RY14P2RY2P2RY4
SCHEMBL9117406 0.82 FBP1 (0.78) FBP1AMDHD2P2RY14IGF2R
SCHEMBL799813 0.82 FBP1 (0.78) FBP1AMDHD2P2RY14IGF2R
SCHEMBL345396 0.82 FBP1 (0.78) FBP1AMDHD2P2RY14IGF2R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8211873-B2 Antiaging chirally-correct mitoprotectant amino acid and peptide complexes ISLAND KINETICS, INC. (US) 2012-07-03 — — US disclosed
US-20100331274-A1 Antiaging Chirally-Correct Mitoprotectant Amino Acid and Peptide Complexes ISLAND KINETICS INC. (US) 2010-12-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100331274-A1 Antiaging Chirally-Correct Mitoprotectant Amino Acid and Peptide Complexes COL14A1, CUTA, POLK FBP1 4722/4885AMDHD2 4297/4885P2RY14 4291/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback